Summit Therapeutics, Inc. (SMMT)
17.90
+2.05
(+12.93%)
USD |
NASDAQ |
May 20, 16:00
17.71
-0.19
(-1.06%)
After-Hours: 07:06
Summit Therapeutics EPS Diluted (Quarterly) : -0.2443 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Revolution Medicines, Inc. | -2.291 |
| BioMarin Pharmaceutical, Inc. | 0.5431 |
| Relay Therapeutics, Inc. | -0.4075 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -189.42M |
| Total Expenses (Quarterly) | 189.42M |
| Enterprise Value | 11.72B |
| Earnings Yield | -8.96% |
| Normalized Earnings Yield | -8.960 |